Therapy Areas: Respiratory
27 March 2024 - Oncology company Novocure (NASDAQ: NVCR) announced on Wednesday the success of its phase 3 METIS clinical trial, revealing a significant improvement in time to intracranial progression...
26 March 2024 - Personalis Inc (Nasdaq: PSNL), a provider of advanced genomics for precision oncology, on Tuesday announced validation of its NeXT Personal test, an ultra-sensitive circulating tumour ...
21 March 2024 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, reported on Thursday that the Phase 3 KEYLYNK-006 trial, evaluating KEYTRUDA (pembroliz...
21 March 2024 - BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company, announced on Wednesday that it has started the Phase 2a portion of its BGBC016 clinical study of its selective A...
20 March 2024 - VolitionRx Limited (NYSE AMERICAN: VNRX) (Volition), a multi-national epigenetics company, announced on Tuesday that it has named Dr Andrew Retter as its new Chief Medical Officer, eff...
19 March 2024 - Pharmaceutical company Dr. Reddy's Laboratories Ltd. (BSE:500124) (NSE:DRREDDY) (NYSE:RDY) (NSEIFSC:DRREDDY), on Tuesday introduced Versavo (bevacizumab) in the UK for treating va...